NDC 51672-4174

Imiquimod

Imiquimod

Imiquimod is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Taro Pharmaceuticals U.s.a., Inc.. The primary component is Imiquimod.

Product ID51672-4174_3f628710-7ac5-41d5-88d1-177bf07bffc5
NDC51672-4174
Product TypeHuman Prescription Drug
Proprietary NameImiquimod
Generic NameImiquimod
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2021-01-26
Marketing CategoryANDA / ANDA
Application NumberANDA205971
Labeler NameTaro Pharmaceuticals U.S.A., Inc.
Substance NameIMIQUIMOD
Active Ingredient Strength38 mg/g
Pharm ClassesIncreased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 51672-4174-6

28 PACKET in 1 CARTON (51672-4174-6) > .25 g in 1 PACKET (51672-4174-8)
Marketing Start Date2021-01-26
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Imiquimod" or generic name "Imiquimod"

NDCBrand NameGeneric Name
0093-3133Imiquimodimiquimod
0168-0432imiquimodimiquimod
45802-368ImiquimodImiquimod
51672-4145ImiquimodImiquimod
51672-4174ImiquimodImiquimod
52549-4145ImiquimodImiquimod
63629-8818Imiquimodimiquimod
64380-773imiquimodimiquimod
68462-536ImiquimodImiquimod
68682-272Imiquimodimiquimod
72189-084IMIQUIMODIMIQUIMOD
99207-260Aldaraimiquimod
99207-270Zyclaraimiquimod
99207-271Zyclaraimiquimod
99207-276Zyclaraimiquimod

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.